Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,562 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hydroxychloroquine plus personal protective equipment versus personal protective equipment alone for the prevention of laboratory-confirmed COVID-19 infections among healthcare workers: a multicentre, parallel-group randomised controlled trial from India.
Tirupakuzhi Vijayaraghavan BK, Jha V, Rajbhandari D, Myatra SN, Ghosh A, Bhattacharya A, Arfin S, Bassi A, Donaldson LH, Hammond NE, John O, Joshi R, Kunigari M, Amrutha C, Husaini SHM, Ghosh S, Nag SK, Selvaraj HK, Kantroo V, Shah KD, Venkatesh B; HOPE Investigators. Tirupakuzhi Vijayaraghavan BK, et al. Among authors: ghosh s, ghosh a. BMJ Open. 2022 Jun 1;12(6):e059540. doi: 10.1136/bmjopen-2021-059540. BMJ Open. 2022. PMID: 35649613 Free PMC article. Clinical Trial.
Hydroxychloroquine plus personal protective equipment versus standard personal protective equipment alone for the prevention of COVID-19 infections among frontline healthcare workers: the HydrOxychloroquine Prophylaxis Evaluation(HOPE) trial: A structured summary of a study protocol for a randomized controlled trial.
Tirupakuzhi Vijayaraghavan BK, Jha V, Rajbhandari D, Myatra SN, John O, Ghosh A, Bassi A, Arfin S, Kunigari M, Joshi R, Donaldson L, Hammond N, Venkatesh B; HOPE investigators. Tirupakuzhi Vijayaraghavan BK, et al. Among authors: ghosh a. Trials. 2020 Aug 31;21(1):754. doi: 10.1186/s13063-020-04679-3. Trials. 2020. PMID: 32867852 Free PMC article.
Colchicine to reduce coronavirus disease-19-related inflammation and cardiovascular complications in high-risk patients post-acute infection with SARS-COV-2-a study protocol for a randomized controlled trial.
Thankachen SS, Devasenapathy N, Bassi A, Ghosh A, Arfin S, Gummidi B, Basheer A, Bangi A, Sahu D, Bhalla A, Blesson M, Jain M, Jha V. Thankachen SS, et al. Among authors: ghosh a. Trials. 2024 Jun 12;25(1):378. doi: 10.1186/s13063-024-08205-7. Trials. 2024. PMID: 38863076 Free PMC article.
Study to Test and Operationalize Preventive Approaches for CKD of Undetermined Etiology in Andhra Pradesh, India.
John O, Gummidi B, Tewari A, Muliyil JP, Ghosh A, Sehgal M, Bassi A, Prinja S, Kumar V, Kalra OP, Kher V, Thakur JS, Ramakrishnan L, Pandey CM, Sivakumar V, Dhaliwal RS, Khanna T, Kumari A, Sharma J, Malakondiah P, Jha V. John O, et al. Among authors: ghosh a. Kidney Int Rep. 2019 Jun 21;4(10):1412-1419. doi: 10.1016/j.ekir.2019.06.003. eCollection 2019 Oct. Kidney Int Rep. 2019. PMID: 31701050 Free PMC article.
Nonmedical Factors and Health-Related Quality of Life in CKD in India.
Modi GK, Yadav AK, Ghosh A, Kamboj K, Kaur P, Kumar V, Bhansali S, Prasad N, Sahay M, Parameswaran S, Varughese S, Gang S, Singh S, Sircar D, Gopalakrishnan N, Jaryal A, Vikrant S, Agarwal SB, Jha V. Modi GK, et al. Among authors: ghosh a. Clin J Am Soc Nephrol. 2020 Feb 7;15(2):191-199. doi: 10.2215/CJN.06510619. Epub 2020 Jan 30. Clin J Am Soc Nephrol. 2020. PMID: 32001488 Free PMC article.
A Systematic Study of the Prevalence and Risk Factors of CKD in Uddanam, India.
Gummidi B, John O, Ghosh A, Modi GK, Sehgal M, Kalra OP, Kher V, Muliyil J, Thakur JS, Ramakrishnan L, Pandey CM, Sivakumar V, Dhaliwal RS, Khanna T, Kumari A, Prasadini G, Reddy JC, Reddy J, Jha V. Gummidi B, et al. Among authors: ghosh a. Kidney Int Rep. 2020 Oct 16;5(12):2246-2255. doi: 10.1016/j.ekir.2020.10.004. eCollection 2020 Dec. Kidney Int Rep. 2020. PMID: 33305118 Free PMC article.
A randomized trial of once daily versus twice daily dosing of oral iron in CKD.
Sood V, Kamboj K, Bhatia P, Sharma V, Kundu M, Ghosh A, Singh SK, Sen T, Kaur P, Ramachandran R, Rathi M, Kohli HS, Gupta KL, Malhotra S, Yadav AK, Kumar V, Jha V. Sood V, et al. Among authors: ghosh a. Sci Rep. 2023 Jan 4;13(1):141. doi: 10.1038/s41598-022-26589-x. Sci Rep. 2023. PMID: 36599872 Free PMC article. Clinical Trial.
Renin-angiotensin blocker use is associated with improved cardiovascular mortality in Indian patients with mild-moderate chronic kidney disease-findings from the ICKD study.
Prasad N, Yadav AK, Kundu M, Jaryal A, Sircar D, Modi G, Sahay M, Gopalakrishnan N, Vikrant S, Varughese S, Baid-Agrawal S, Singh S, Gang S, Parameswaran S, Ghosh A, Kumar V, Jha V. Prasad N, et al. Among authors: ghosh a. Front Med (Lausanne). 2022 Dec 20;9:1060148. doi: 10.3389/fmed.2022.1060148. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36606058 Free PMC article.
7,562 results